Viewing nowCombinationCadenza 10/160mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.

MFDS item code 201403457 · Approved 2014.07.29 · Insurance code 644003480
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before starting this medicine; however, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication is contraindicated in certain patients. For example, it should not be taken by individuals with allergies to its components or similar medications, pregnant or breastfeeding women, those with severe renal or liver disease, and patients with a history of certain heart diseases or vascular edema. Patients with a deficiency of sodium or fluids in the body should correct this condition before taking the medication, and blood pressure should be monitored closely during treatment. Caution is needed when this medication is used in conjunction with potassium-increasing medications for patients with high potassium levels, and regular monitoring of potassium levels is necessary. Patients with renal vascular stenosis or those who have received a kidney transplant should be monitored closely as this medication may affect renal function. If swelling of the face, lips, tongue, etc., occurs during the course of treatment, the medication should be stopped immediately, and healthcare personnel should be informed. For patients with heart failure or after myocardial infarction, meticulous monitoring of renal function and blood pressure is required, as symptoms of heart failure may worsen. The risk of hypotension, changes in renal function, hyperkalemia, and other issues may increase when this medication is used in combination with other antihypertensives or specific drugs; therefore, consultation with a physician is recommended. Dizziness or fatigue may occur while driving or operating machinery; hence, caution is necessary. In the event of overdose, severe hypotension or cardiac issues may arise; therefore, the dosage must be strictly adhered to. This medication is not recommended for children under 18 years of age due to insufficient evidence of safety and efficacy. Elderly patients are recommended similar dosages as adults, but caution may be necessary depending on individual conditions. Regular checks of blood pressure, renal function, and electrolyte levels should be performed while taking this medication to monitor for abnormalities. Women who are pregnant or planning to become pregnant, as well as lactating women, should avoid using this medication and discontinue it immediately if pregnancy is confirmed during treatment.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, frequency of urination, polyuria, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, muscular hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, pruritus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It should be kept at room temperature between 1 to 30 degrees Celsius, away from extreme cold or heat.
Bright yellow, oval film-coated tablet
Domestic - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Samik Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.